ABSTRACT Rheumatoid arthritis is significantly associated with the HLA determinant HLA-DRw4 and cell-mediated reactivity to collagen. To determine ifgenes linked to those coding for HLA-DRw4 constituted immune response genes for collagen reactivity, peripheral blood mononuclear cells from 20 individuals with rheumatoid arthritis, 13 individuals with other arthropathies, and 41 normal individuals were compared for their ability to synthesize the lymphokine leukocyte inhibition factor in response to denatured bovine collagen. All individuals were responsive to the control antigen Candida albicans. While 90% of the patients with rheumatoid arthritis responded to collagen, so did 30% of the individuals without rheumatoid arthritis. This included 15 normal individuals without any evidence of arthritis. Collagen responsiveness was dependent on interactions between T cells and macrophages and was directed against determinants expressed by primary amino acid sequences in the synthetic polypeptide (GlyPro).. HLA-DRw typing of 59 individuals revealed a highly significant relationship (P < 0.0001, x2 = 33.7) between and collagen responsiveness, irrespective of whether or not rheumatoid arthritis was present. All normal individuals who were HLA-DRw4-positive were collagen responders. These studies demonstrate that the cellular, molecular, and genetic characteristics of collagen reactivity in man parallel those documented for the T cell-dependent response to antigens under immune response gene control in rodents.
Immune response (Ir) gene control ofT cell reactivity to soluble antigens in rodents demonstrates the following characteristics. First, the depicted reactivity requires presentation of antigen by macrophages (MO) to reactive T cells and is thus both MO and T cell dependent (1) (2) (3) . Second, the reactivity is specific for determinants inherent in linear amino acid sequences of synthetic polypeptides or limited regions ofglobular proteins (4) (5) (6) (7) . That is to say, it is not dependent on conformational determinants dictated by tertiary structure. Third, the reactivity is controlled by genes closely linked to those in the Ir region of the major histocompatability complex (MHC) (2, 4) .
Previous studies from this laboratory demonstrated that murine T cell reactivity to denatured beef collagen, as measured by proliferation in vitro, was linked to Ir genes (8) . This finding, coupled with the observations of others that (i) T cell reactivity to collagen in man is seen in a high proportion of patients with rheumatoid arthritis (9) (10) (11) (12) and (ii) rheumatoid arthritis is significantly associated with cell surface determinants (HLA-Dw4 and HLA-DRw4) that are products of genes in the proposed human Ir locus, suggested that collagen reactivity in man might also be under Ir gene control (13, 14) . The results ofthe studies presented here indicate that the cellular and antigenic requirements for collagen-induced production of leukocyte inhibition factor (LIF) in man parallel those established for Ir gene control ofT cell reactivity in rodents. Most importantly, in both normal individuals and patients with rheumatoid arthritis, this reactivity is significantly associated with HLA-DRw4.
MATERIALS AND METHODS
The patient population consisted of20 individuals, all Caucasian (mean age ± SEM = 53 + 2 years) with classic or definite rheumatoid arthritis as defined by criteria from the American Rheumatism Association, and 13 individuals (mean age = 49 + 4 years) with other arthropathies (osteoarthritis,7; psoriatic arthritis,2; pauciarticular juvenile rheumatoid arthritis,2; Reiter syndrome, 1; ankylosing spondylitis, 1). The patients were chosen by consecutive admission to the outpatient clinic or inpatient service. Patients receiving corticosteroids, cytotoxic drugs, or penicillamine were not included. Four patients (three with rheumatoid arthritis, one with juvenile rheumatoid arthritis were receiving gold injections and all patients were taking some form of oral, nonsteroidal, anti-inflammatory medication. Normals (mean age = 28 ± 6 years) consisted of 41 individuals (39 Caucasian, 2 Oriental) chosen at random from a pool of normal blood donors.
Lymphocyte Reactivity. Antigens used to determine reactivity in vitro included the following: Candida albicans (Hollister-Steir Laboratories, Toronto, Ontario, dialyzed against phosphate-buffered saline, pH 7.4); collagen prepared from bovine achilles tendon [Sigma; dissolved and denatured as described (8)], the synthetic polypeptides (Gly-Sar-Pro)n (Sar, sarcosine), mean molecular weight 15,500, (Gly-Pro)n, mean molecular weight 11,000, (Pro)n, mean molecular weight 37,000; type I and type II collagen isolated from lathrytic chicken embryos; and proteoglycan, prepared as described (15) (16) (17) (the type I and type II collagen as well as the proteoglycan were purified to homogeneity as determined by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and were generous gifts of Robert Siegel).
Reactivity to these antigens was determined utilizing an indirect assay for the production of LIF as described (18 The concentration of each antigen used to induce LIF production was determined by plotting a dose-response curve utilizing peripheral blood mononuclear cells (PBMC) from several different responder individuals and concentrations of each antigen ranging between 50 and 400 Ag/ml. These studies indicated a relatively flat dose response in that bovine collagen and each of the synthetic polypeptides at 50, 100, and 150 ug/ ml all elicited maximal LIF production. Thus, 100 ug/ml of each ofthese four antigens, as well as 100 Ag/ml ofchicken type I and type II collagen and proteoglycan, was used throughout the study. In four individuals who failed to synthesize LIF in response to the bovine collagen or each of the collagen peptides at 100 tug/ml, complete dose-response curves were determined. In none of these individuals was LIF production induced by any concentration of the antigens tested. Two individuals, both normal controls, were deleted from the study because the control antigen, C. albicans, failed to induce production of LIF sufficient to cause >20% inhibition ofleukocyte migration.
Monoclonal Antibodies. The characteristics of two monoclonal antibodies used to determine the requirement for T cells or MOin collagen-induced LIF production have been described (19, 20) . Briefly, T-29 is a K IgG2b monoclonal immunoglobulin that, by immunofluorescence and cytotoxicity, depicts determinants on 9.8 ± 2% of the T cells from several different individuals. The antibody does not interact with B cells or Mo.
Mac-120 is a K IgM monoclonal antibody that, in the same assay systems, interacts with a 120,000-dalton determinant displayed by 38 ± 3% of adherent, peripheral blood Mo but does not interact with T cells, null cells, or B cells. Immunoglobulin purified by an affinity column (goat antiTmouse Ig) was used in an indirect cytotoxicity assay (monoclonal antibody + goat antimouse Ig + complement) to remove target cells as described (19) .
HLA-DR Typing. HLA-DR typing was performed in the laboratory of Paul I. Terasaki, utilizing a panel of 38 reagents that depict six HLA-DRw determinants (HLA-DRw 1-5 and 7). RESULTS C. albicans and Collagen-Induced LIF Production. C. albicans and denatured bovine collagen were compared for their ability to induce LIF production among 20 patients with rheumatoid arthritis and 54 "others" (13 individuals with arthropathies other than rheumatoid arthritis and 41 normal controls; Fig. 1 ). All individuals were responders to C. albicans (>20% inhibition ofmigration). While 90% ofpatients with rheumatoid arthritis were collagen responders, so were 30% of individuals without rheumatoid arthritis (2 individuals with osteoarthritis, 1 with pauci-articular juvenile rheumatoid arthritis, and 15 normals). Thus, reactivity to collagen was not restricted to patients with rheumatoid arthritis.
As indicated in Materials and Methods, four collagen nonresponders tested failed to respond to any offive concentrations of the bovine collagen used, indicating that collagen unresponsiveness did not reflect the use of a suboptimal concentration of antigen. Collagen responders (mean ± SEM, 46.9 ± 3.7% inhibition of migration) and nonresponders (8.0 ± 1.8% inhibition of migration) synthesized comparable amounts of LIF in response to C. albicans (41.5 ± 4.0% and 35.8 ± 3.5% inhibition ofmigration, respectively), and regression analysis of the data presented in Fig. 1 failed to substantiate any direct relationship between the reactivity to C. albicans and collagen (correlation coefficient of only 0.37). Thus, collagen responsiveness did not simply reflect a generalized increase in antigen reactivity.
Cellular and Antigenic Requirements for Collagen Reactivity. It has been suggested that production of LIF in vitro requires the activation of antigen-specific T cells. Other assays PBMC from individuals responsive to C. albicans and bovine collagen were cytolytically treated with a control reagent (MIg), the T cellspecific monoclonal antibody T-29, or the MO-specific monoclonal antibody Mac-120. The recovered cells were then resuspended to equivalent concentrations ofviable cells and tested for their synthesis ofLIF in response to C. albicans or collagen. T-29 added to Mac-120 refers to two different samples of PBMC that were first treated with the respective monoclonal antibody and then mixed in a ratio of 1:1. ND, not done. Individuals were grouped into responders (8) and nonresponders (3) on the basis of their response to commercial bovine collagen. LIF production in response to purified chicken type I collagen, chicken type II collagen, and proteoglycan was then tested.
is structurally distinct from collagen, did not induce LIF production among collagen responders ( Table 2 ).
The three a chains of collagen exist as a triple helix when collagen is in its native form. The finding that denatured collagen elicits reactivity suggests that the relevant antigenic determinant is not a conformational one dependent on tertiary structure. This is supported by the data presented in Fig. 2 .
While the synthetic peptides (Gly-Sar-Pro). and (Gly-Pro)" each bear linear sequence similarity to collagen a chains, neither demonstrates tertiary structure in aqueous solution (23, 24) . Both polypeptides could induce LIF production among collagen responders comparable to that seen upon using the denatured bovine collagen. The synthetic polypeptide (Pro)n, which does not demonstrate linear sequence similarity to collagen, failed to elicit reactivity.
HLA-DRw Phenotypes of Collagen Responders and Nonresponders. To determine if collagen reactivity is associated with a specific HLA-DR determinant, PBMC from 59 individuals (15 rheumatoid arthritis patients, 6 patients with other arthropathies, and 38 normals) were HLA-DRw typed. Sixtyseven percent ofpatients with rheumatoid arthritis and 29% of normals were HLA-DRw4-positive. These frequencies ofHLADRw4 positivity are comparable to those previously reported and emphasize the association between rheumatoid arthritis and HLA-DRw4 (13, 14) . All HLA-DRw4-positive individuals (21) were collagen responders, including 11 normals without any evidence of arthritis (Table 3) . Conversely, of the 29 collagen responders, 21 were HLA-DRw4 positive. This association between HLA-DRw4 positivity and collagen responsiveness was significant at the level ofP < 0.0001 (X2 = 33.7). HLADRw4 positivity did not correlate with any significant difference in LIF production occurring in response to C. albicans (HLADRw4+ = 39.0 ± 4.6% inhibition of migration, HLA-DRw4-= 32.7 ± 3.4% inhibition of migration; P = 0.3). A similar association between responsiveness and HLA-DRw4 positivity was noted upon using the collagen-related peptide (Gly-Pro)n (data not presented). It should be emphasized that HLA-DR typing was performed without prior knowledge of an individual's reactivity to collagen. It was not possible to perform HLA-DR typing on 15 individuals (7 collagen responders, 8 nonresponders) because of a failure to obtain a sufficient quantity of peripheral blood. LIF production in response to denatured bovine collagen and collagen-related peptides. For these experiments, collagen responders and nonresponders were grouped irrespective ofthe presence ofany associated disease. LIF production occurring in response to the commercial denatured bovine collagen and three collagen-related peptides is presented. *, Responders (>20% inhibition ofmigration to bovine collagen); o, nonresponders. The mean ± SEM for each group is indicated by the points with error bars.
DISCUSSION
The data presented here indicate that T cell-dependent reactivity to collagen in man is under Ir gene control. This conclusion is dependent on the following three points: first, that the LIF assay used to measure reactivity depicts the presence of collagen-reactive T cells; second, that the antigen eliciting LIF production is collagen; and third, that genes determining this reactivity are linked to those in the human Ir locus.
While it is clear that antigen-induced production of LIF reflects activation of antigen-reactive immunocytes, the exact nature ofthe cells that synthesize this lymphokine is controversial (25, 26) . When considered together, the results of published studies indicate that while M and T cells constitute an absolute This is a 2 x 2 analysis of the relationship between collagen reactivity and the presence of the HLA-DRw4 phenotype in patients with rheumatoid arthritis as well as in individuals with other forms of arthropathies and normals (these latter two groups are referred to as "others"). Only individuals in whom it was possible to assay for both collagen-induced LIF production and HLA-DR phenotypes are included. The x2 for the relationship between collagen responsiveness and HLA-DRw4 is 33.7, with a P value of less than 0.0001. requirement for LIF production, activated T cells may, in turn, "help" B cells synthesize LIF (27) (28) (29) . One study has suggested that isolated B cells synthesize substantial amounts of LIF in the absence of T cells, but the method used for isolating the B cells (i.e., attachment to anti-Ig linked to solid support) may have provided an activating signal sufficient to substitute for Tdependent "help" (26) . We cannot rule out the possibility that B cells existing among whole PBMC contribute to collagen-induced production of LIF. Nonetheless, the data presented in Table 1 indicate that the reactivity to collagen measured here is dependent on interactions between MO and T cells that are also required for reactivity to other conventional antigens (19, 20) .
The studies presented in Fig. 2 and Table 2 demonstrate that reactivity equivalent to that noted in response to the commercial bovine collagen could be elicited with purified type I and type II chicken collagen and collagen-related synthetic polypeptides but not with (Pro),, or proteoglycan. These findings support three conclusions. First, they indicate that the depicted reactivity is specific for antigenic determinants displayed by collagen. Second, they demonstrate that the determinants recognized are inherent in linear amino acid sequences. Neither (Gly-Pro),, nor (Gly-Sar-Pro),, demonstrate "collagen-like" helical structure in aqueous solution (23) . This is consistent with the documented specificity of T (10, 12) .
Compelling evidence indicates that the genes in the HLA-D locus of the human MHC are homologous to rodent Ir genes. For example, products of HLA-D genes demonstrate a tissue distribution, ability to stimulate in an allogeneic mixed lymnphocyte reaction, and structure similar to that documented for murine Jr gene products (30, 31) . Moreover, genes associated with the HLA-D region have been implicated in determining the response to immunodominant determinants in tetanus toxoid, schistosomal worm antigens, and native DNA (32) (33) (34) . The conclusion that reactivity to collagen is controlled by Ir genes linked to those coding for HLA-DRw4 is not based on the association between HLA-DRw4 and collagen reactivity in patients with rheumatoid arthritis. Instead, it is the finding ofcollagen responsiveness among all 11 normal HLA-DRw4-positive individuals that suggests an association between collagen Ir genes and those coding for HLA-DRw4 that is independent of active synovitis. Eight collagen responders lacked the HLADRw4 phenotype. However, six of these were positive for the HLA-DRw7 phenotype, which may share a serologically defined determinant with HLA-DRw4 (14) .
Thus, the studies presented here support the conclusion that genes linked to those coding for HLA-DRw4 constitute Ir genes for T cell-dependent reactivity to collagen. On the basis ofthese studies, we suggest that during the physiologic degradation of collagen, all individuals are exposed to (Gly-Pro) determinants normally buried in the interstices of the collagen triple helix. However, only those individuals whose MHC contains the HLA-DRw4-linked Ir genes manifest observable reactivity. This model is consistent with the findings ofothers demonstrating collagen reactivity in 10-28% ofnormal individuals (10) (11) (12) . Our findings do differ from those of Smolen et al. (12) which failed to demonstrate a significant association between proliferative reactivity to collagen and HLA-DRw4 in patients with rheumatoid arthritis. However, in this study it was not demonstrated that the HLA-DRw4-positive collagen nonresponders could respond to a control antigen. Thus, their failure to manifest collagen reactivity might represent a generalized immunologic unresponsiveness related either to disease activity or medications. We have not been able to depict collagen-induced blastogenesis among PBMC that is significantly increased above background proliferation. This may reflect the fact that the T cell repertoire specific for determinants inherent in (Gly-Pro) is small.
The studies presented here do not allow any conclusions concerning the contribution of collagen reactivity to the development of clinically apparent rheumatoid arthritis other than to clearly indicate that such reactivity is not in itself sufficient for the expression of disease. They do, however, provide a model useful for exploring this 
